Global Recombinant Parvovirus Antigens Market Growth (Status and Outlook) 2026-2032

May 2026 | 71 pages | ID: GF053F0E02BFEN
LP Information

Abstracts

The global Recombinant Parvovirus Antigens market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.

United States market for Recombinant Parvovirus Antigens is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for Recombinant Parvovirus Antigens is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for Recombinant Parvovirus Antigens is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key Recombinant Parvovirus Antigens players cover ELlTechGroup, Diesse Diagnostica Senese, R-Biopharm AG, Zoetis, altona Diagnostics GmbH, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

LPI (LP Information)' newest research report, the “Recombinant Parvovirus Antigens Industry Forecast” looks at past sales and reviews total world Recombinant Parvovirus Antigens sales in 2025, providing a comprehensive analysis by region and market sector of projected Recombinant Parvovirus Antigens sales for 2026 through 2032. With Recombinant Parvovirus Antigens sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Recombinant Parvovirus Antigens industry.

This Insight Report provides a comprehensive analysis of the global Recombinant Parvovirus Antigens landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Recombinant Parvovirus Antigens portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Recombinant Parvovirus Antigens market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Recombinant Parvovirus Antigens and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Recombinant Parvovirus Antigens.

This report presents a comprehensive overview, market shares, and growth opportunities of Recombinant Parvovirus Antigens market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Antigen NS1
• Antigen VP1
• Antigen VP2
• Others

Segmentation by Application:

• Hospital
• Diagnostic Laboratory
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• ELlTechGroup
• Diesse Diagnostica Senese
• R-Biopharm AG
• Zoetis
• altona Diagnostics GmbH

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Recombinant Parvovirus Antigens Market Size (2021-2032)
  2.1.2 Recombinant Parvovirus Antigens Market Size CAGR by Region (2021 VS 2025 VS 2032)
  2.1.3 World Current & Future Analysis for Recombinant Parvovirus Antigens by Country/Region (2021, 2025 & 2032)
2.2 Recombinant Parvovirus Antigens Segment by Type
  2.2.1 Antigen NS1
  2.2.2 Antigen VP1
  2.2.3 Antigen VP2
  2.2.4 Others
  2.2.5 Recombinant Parvovirus Antigens Market Size by Type
    2.2.5.1 Recombinant Parvovirus Antigens Market Size CAGR by Type (2021 VS 2025 VS 2032)
    2.2.5.2 Global Recombinant Parvovirus Antigens Market Size Market Share by Type (2021-2026)
2.3 Recombinant Parvovirus Antigens Segment by Application
  2.3.1 Hospital
  2.3.2 Diagnostic Laboratory
  2.3.3 Others
  2.3.4 Recombinant Parvovirus Antigens Market Size by Application
    2.3.4.1 Recombinant Parvovirus Antigens Market Size CAGR by Application (2021 VS 2025 VS 2032)
    2.3.4.2 Global Recombinant Parvovirus Antigens Market Size Market Share by Application (2021-2026)

3 RECOMBINANT PARVOVIRUS ANTIGENS MARKET SIZE BY PLAYER

3.1 Recombinant Parvovirus Antigens Market Size Market Share by Player
  3.1.1 Global Recombinant Parvovirus Antigens Revenue by Player (2021-2026)
  3.1.2 Global Recombinant Parvovirus Antigens Revenue Market Share by Player (2021-2026)
3.2 Global Recombinant Parvovirus Antigens Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 RECOMBINANT PARVOVIRUS ANTIGENS BY REGION

4.1 Recombinant Parvovirus Antigens Market Size by Region (2021-2026)
4.2 Global Recombinant Parvovirus Antigens Annual Revenue by Country/Region (2021-2026)
4.3 Americas Recombinant Parvovirus Antigens Market Size Growth (2021-2026)
4.4 APAC Recombinant Parvovirus Antigens Market Size Growth (2021-2026)
4.5 Europe Recombinant Parvovirus Antigens Market Size Growth (2021-2026)
4.6 Middle East & Africa Recombinant Parvovirus Antigens Market Size Growth (2021-2026)

5 AMERICAS

5.1 Americas Recombinant Parvovirus Antigens Market Size by Country (2021-2026)
5.2 Americas Recombinant Parvovirus Antigens Market Size by Type (2021-2026)
5.3 Americas Recombinant Parvovirus Antigens Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Recombinant Parvovirus Antigens Market Size by Region (2021-2026)
6.2 APAC Recombinant Parvovirus Antigens Market Size by Type (2021-2026)
6.3 APAC Recombinant Parvovirus Antigens Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Recombinant Parvovirus Antigens Market Size by Country (2021-2026)
7.2 Europe Recombinant Parvovirus Antigens Market Size by Type (2021-2026)
7.3 Europe Recombinant Parvovirus Antigens Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Recombinant Parvovirus Antigens by Region (2021-2026)
8.2 Middle East & Africa Recombinant Parvovirus Antigens Market Size by Type (2021-2026)
8.3 Middle East & Africa Recombinant Parvovirus Antigens Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL RECOMBINANT PARVOVIRUS ANTIGENS MARKET FORECAST

10.1 Global Recombinant Parvovirus Antigens Forecast by Region (2027-2032)
  10.1.1 Global Recombinant Parvovirus Antigens Forecast by Region (2027-2032)
  10.1.2 Americas Recombinant Parvovirus Antigens Forecast
  10.1.3 APAC Recombinant Parvovirus Antigens Forecast
  10.1.4 Europe Recombinant Parvovirus Antigens Forecast
  10.1.5 Middle East & Africa Recombinant Parvovirus Antigens Forecast
10.2 Americas Recombinant Parvovirus Antigens Forecast by Country (2027-2032)
  10.2.1 United States Market Recombinant Parvovirus Antigens Forecast
  10.2.2 Canada Market Recombinant Parvovirus Antigens Forecast
  10.2.3 Mexico Market Recombinant Parvovirus Antigens Forecast
  10.2.4 Brazil Market Recombinant Parvovirus Antigens Forecast
10.3 APAC Recombinant Parvovirus Antigens Forecast by Region (2027-2032)
  10.3.1 China Recombinant Parvovirus Antigens Market Forecast
  10.3.2 Japan Market Recombinant Parvovirus Antigens Forecast
  10.3.3 Korea Market Recombinant Parvovirus Antigens Forecast
  10.3.4 Southeast Asia Market Recombinant Parvovirus Antigens Forecast
  10.3.5 India Market Recombinant Parvovirus Antigens Forecast
  10.3.6 Australia Market Recombinant Parvovirus Antigens Forecast
10.4 Europe Recombinant Parvovirus Antigens Forecast by Country (2027-2032)
  10.4.1 Germany Market Recombinant Parvovirus Antigens Forecast
  10.4.2 France Market Recombinant Parvovirus Antigens Forecast
  10.4.3 UK Market Recombinant Parvovirus Antigens Forecast
  10.4.4 Italy Market Recombinant Parvovirus Antigens Forecast
  10.4.5 Russia Market Recombinant Parvovirus Antigens Forecast
10.5 Middle East & Africa Recombinant Parvovirus Antigens Forecast by Region (2027-2032)
  10.5.1 Egypt Market Recombinant Parvovirus Antigens Forecast
  10.5.2 South Africa Market Recombinant Parvovirus Antigens Forecast
  10.5.3 Israel Market Recombinant Parvovirus Antigens Forecast
  10.5.4 Turkey Market Recombinant Parvovirus Antigens Forecast
10.6 Global Recombinant Parvovirus Antigens Forecast by Type (2027-2032)
10.7 Global Recombinant Parvovirus Antigens Forecast by Application (2027-2032)
  10.7.1 GCC Countries Market Recombinant Parvovirus Antigens Forecast

11 KEY PLAYERS ANALYSIS

11.1 ELlTechGroup
  11.1.1 ELlTechGroup Company Information
  11.1.2 ELlTechGroup Recombinant Parvovirus Antigens Product Offered
  11.1.3 ELlTechGroup Recombinant Parvovirus Antigens Revenue, Gross Margin and Market Share (2021-2026)
  11.1.4 ELlTechGroup Main Business Overview
  11.1.5 ELlTechGroup Latest Developments
11.2 Diesse Diagnostica Senese
  11.2.1 Diesse Diagnostica Senese Company Information
  11.2.2 Diesse Diagnostica Senese Recombinant Parvovirus Antigens Product Offered
  11.2.3 Diesse Diagnostica Senese Recombinant Parvovirus Antigens Revenue, Gross Margin and Market Share (2021-2026)
  11.2.4 Diesse Diagnostica Senese Main Business Overview
  11.2.5 Diesse Diagnostica Senese Latest Developments
11.3 R-Biopharm AG
  11.3.1 R-Biopharm AG Company Information
  11.3.2 R-Biopharm AG Recombinant Parvovirus Antigens Product Offered
  11.3.3 R-Biopharm AG Recombinant Parvovirus Antigens Revenue, Gross Margin and Market Share (2021-2026)
  11.3.4 R-Biopharm AG Main Business Overview
  11.3.5 R-Biopharm AG Latest Developments
11.4 Zoetis
  11.4.1 Zoetis Company Information
  11.4.2 Zoetis Recombinant Parvovirus Antigens Product Offered
  11.4.3 Zoetis Recombinant Parvovirus Antigens Revenue, Gross Margin and Market Share (2021-2026)
  11.4.4 Zoetis Main Business Overview
  11.4.5 Zoetis Latest Developments
11.5 altona Diagnostics GmbH
  11.5.1 altona Diagnostics GmbH Company Information
  11.5.2 altona Diagnostics GmbH Recombinant Parvovirus Antigens Product Offered
  11.5.3 altona Diagnostics GmbH Recombinant Parvovirus Antigens Revenue, Gross Margin and Market Share (2021-2026)
  11.5.4 altona Diagnostics GmbH Main Business Overview
  11.5.5 altona Diagnostics GmbH Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Recombinant Parvovirus Antigens Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Recombinant Parvovirus Antigens Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Antigen NS1
Table 4. Major Players of Antigen VP1
Table 5. Major Players of Antigen VP2
Table 6. Major Players of Others
Table 7. Recombinant Parvovirus Antigens Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global Recombinant Parvovirus Antigens Market Size by Type (2021-2026) & ($ millions)
Table 9. Global Recombinant Parvovirus Antigens Market Size Market Share by Type (2021-2026)
Table 10. Recombinant Parvovirus Antigens Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 11. Global Recombinant Parvovirus Antigens Market Size by Application (2021-2026) & ($ millions)
Table 12. Global Recombinant Parvovirus Antigens Market Size Market Share by Application (2021-2026)
Table 13. Global Recombinant Parvovirus Antigens Revenue by Player (2021-2026) & ($ millions)
Table 14. Global Recombinant Parvovirus Antigens Revenue Market Share by Player (2021-2026)
Table 15. Recombinant Parvovirus Antigens Key Players Head office and Products Offered
Table 16. Recombinant Parvovirus Antigens Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Recombinant Parvovirus Antigens Market Size by Region (2021-2026) & ($ millions)
Table 20. Global Recombinant Parvovirus Antigens Market Size Market Share by Region (2021-2026)
Table 21. Global Recombinant Parvovirus Antigens Revenue by Country/Region (2021-2026) & ($ millions)
Table 22. Global Recombinant Parvovirus Antigens Revenue Market Share by Country/Region (2021-2026)
Table 23. Americas Recombinant Parvovirus Antigens Market Size by Country (2021-2026) & ($ millions)
Table 24. Americas Recombinant Parvovirus Antigens Market Size Market Share by Country (2021-2026)
Table 25. Americas Recombinant Parvovirus Antigens Market Size by Type (2021-2026) & ($ millions)
Table 26. Americas Recombinant Parvovirus Antigens Market Size Market Share by Type (2021-2026)
Table 27. Americas Recombinant Parvovirus Antigens Market Size by Application (2021-2026) & ($ millions)
Table 28. Americas Recombinant Parvovirus Antigens Market Size Market Share by Application (2021-2026)
Table 29. APAC Recombinant Parvovirus Antigens Market Size by Region (2021-2026) & ($ millions)
Table 30. APAC Recombinant Parvovirus Antigens Market Size Market Share by Region (2021-2026)
Table 31. APAC Recombinant Parvovirus Antigens Market Size by Type (2021-2026) & ($ millions)
Table 32. APAC Recombinant Parvovirus Antigens Market Size by Application (2021-2026) & ($ millions)
Table 33. Europe Recombinant Parvovirus Antigens Market Size by Country (2021-2026) & ($ millions)
Table 34. Europe Recombinant Parvovirus Antigens Market Size Market Share by Country (2021-2026)
Table 35. Europe Recombinant Parvovirus Antigens Market Size by Type (2021-2026) & ($ millions)
Table 36. Europe Recombinant Parvovirus Antigens Market Size by Application (2021-2026) & ($ millions)
Table 37. Middle East & Africa Recombinant Parvovirus Antigens Market Size by Region (2021-2026) & ($ millions)
Table 38. Middle East & Africa Recombinant Parvovirus Antigens Market Size by Type (2021-2026) & ($ millions)
Table 39. Middle East & Africa Recombinant Parvovirus Antigens Market Size by Application (2021-2026) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Recombinant Parvovirus Antigens
Table 41. Key Market Challenges & Risks of Recombinant Parvovirus Antigens
Table 42. Key Industry Trends of Recombinant Parvovirus Antigens
Table 43. Global Recombinant Parvovirus Antigens Market Size Forecast by Region (2027-2032) & ($ millions)
Table 44. Global Recombinant Parvovirus Antigens Market Size Market Share Forecast by Region (2027-2032)
Table 45. Global Recombinant Parvovirus Antigens Market Size Forecast by Type (2027-2032) & ($ millions)
Table 46. Global Recombinant Parvovirus Antigens Market Size Forecast by Application (2027-2032) & ($ millions)
Table 47. ELlTechGroup Details, Company Type, Recombinant Parvovirus Antigens Area Served and Its Competitors
Table 48. ELlTechGroup Recombinant Parvovirus Antigens Product Offered
Table 49. ELlTechGroup Recombinant Parvovirus Antigens Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 50. ELlTechGroup Main Business
Table 51. ELlTechGroup Latest Developments
Table 52. Diesse Diagnostica Senese Details, Company Type, Recombinant Parvovirus Antigens Area Served and Its Competitors
Table 53. Diesse Diagnostica Senese Recombinant Parvovirus Antigens Product Offered
Table 54. Diesse Diagnostica Senese Recombinant Parvovirus Antigens Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 55. Diesse Diagnostica Senese Main Business
Table 56. Diesse Diagnostica Senese Latest Developments
Table 57. R-Biopharm AG Details, Company Type, Recombinant Parvovirus Antigens Area Served and Its Competitors
Table 58. R-Biopharm AG Recombinant Parvovirus Antigens Product Offered
Table 59. R-Biopharm AG Recombinant Parvovirus Antigens Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 60. R-Biopharm AG Main Business
Table 61. R-Biopharm AG Latest Developments
Table 62. Zoetis Details, Company Type, Recombinant Parvovirus Antigens Area Served and Its Competitors
Table 63. Zoetis Recombinant Parvovirus Antigens Product Offered
Table 64. Zoetis Recombinant Parvovirus Antigens Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 65. Zoetis Main Business
Table 66. Zoetis Latest Developments
Table 67. altona Diagnostics GmbH Details, Company Type, Recombinant Parvovirus Antigens Area Served and Its Competitors
Table 68. altona Diagnostics GmbH Recombinant Parvovirus Antigens Product Offered
Table 69. altona Diagnostics GmbH Recombinant Parvovirus Antigens Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 70. altona Diagnostics GmbH Main Business
Table 71. altona Diagnostics GmbH Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Recombinant Parvovirus Antigens Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Recombinant Parvovirus Antigens Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Recombinant Parvovirus Antigens Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Recombinant Parvovirus Antigens Sales Market Share by Country/Region (2025)
Figure 8. Recombinant Parvovirus Antigens Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Recombinant Parvovirus Antigens Market Size Market Share by Type in 2025
Figure 10. Recombinant Parvovirus Antigens in Hospital
Figure 11. Global Recombinant Parvovirus Antigens Market: Hospital (2021-2026) & ($ millions)
Figure 12. Recombinant Parvovirus Antigens in Diagnostic Laboratory
Figure 13. Global Recombinant Parvovirus Antigens Market: Diagnostic Laboratory (2021-2026) & ($ millions)
Figure 14. Recombinant Parvovirus Antigens in Others
Figure 15. Global Recombinant Parvovirus Antigens Market: Others (2021-2026) & ($ millions)
Figure 16. Global Recombinant Parvovirus Antigens Market Size Market Share by Application in 2025
Figure 17. Global Recombinant Parvovirus Antigens Revenue Market Share by Player in 2025
Figure 18. Global Recombinant Parvovirus Antigens Market Size Market Share by Region (2021-2026)
Figure 19. Americas Recombinant Parvovirus Antigens Market Size 2021-2026 ($ millions)
Figure 20. APAC Recombinant Parvovirus Antigens Market Size 2021-2026 ($ millions)
Figure 21. Europe Recombinant Parvovirus Antigens Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Recombinant Parvovirus Antigens Market Size 2021-2026 ($ millions)
Figure 23. Americas Recombinant Parvovirus Antigens Value Market Share by Country in 2025
Figure 24. United States Recombinant Parvovirus Antigens Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Recombinant Parvovirus Antigens Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Recombinant Parvovirus Antigens Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Recombinant Parvovirus Antigens Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Recombinant Parvovirus Antigens Market Size Market Share by Region in 2025
Figure 29. APAC Recombinant Parvovirus Antigens Market Size Market Share by Type (2021-2026)
Figure 30. APAC Recombinant Parvovirus Antigens Market Size Market Share by Application (2021-2026)
Figure 31. China Recombinant Parvovirus Antigens Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Recombinant Parvovirus Antigens Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Recombinant Parvovirus Antigens Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Recombinant Parvovirus Antigens Market Size Growth 2021-2026 ($ millions)
Figure 35. India Recombinant Parvovirus Antigens Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Recombinant Parvovirus Antigens Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Recombinant Parvovirus Antigens Market Size Market Share by Country in 2025
Figure 38. Europe Recombinant Parvovirus Antigens Market Size Market Share by Type (2021-2026)
Figure 39. Europe Recombinant Parvovirus Antigens Market Size Market Share by Application (2021-2026)
Figure 40. Germany Recombinant Parvovirus Antigens Market Size Growth 2021-2026 ($ millions)
Figure 41. France Recombinant Parvovirus Antigens Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Recombinant Parvovirus Antigens Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Recombinant Parvovirus Antigens Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Recombinant Parvovirus Antigens Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Recombinant Parvovirus Antigens Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Recombinant Parvovirus Antigens Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Recombinant Parvovirus Antigens Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Recombinant Parvovirus Antigens Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Recombinant Parvovirus Antigens Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Recombinant Parvovirus Antigens Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Recombinant Parvovirus Antigens Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Recombinant Parvovirus Antigens Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Recombinant Parvovirus Antigens Market Size 2027-2032 ($ millions)
Figure 54. APAC Recombinant Parvovirus Antigens Market Size 2027-2032 ($ millions)
Figure 55. Europe Recombinant Parvovirus Antigens Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Recombinant Parvovirus Antigens Market Size 2027-2032 ($ millions)
Figure 57. United States Recombinant Parvovirus Antigens Market Size 2027-2032 ($ millions)
Figure 58. Canada Recombinant Parvovirus Antigens Market Size 2027-2032 ($ millions)
Figure 59. Mexico Recombinant Parvovirus Antigens Market Size 2027-2032 ($ millions)
Figure 60. Brazil Recombinant Parvovirus Antigens Market Size 2027-2032 ($ millions)
Figure 61. China Recombinant Parvovirus Antigens Market Size 2027-2032 ($ millions)
Figure 62. Japan Recombinant Parvovirus Antigens Market Size 2027-2032 ($ millions)
Figure 63. Korea Recombinant Parvovirus Antigens Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Recombinant Parvovirus Antigens Market Size 2027-2032 ($ millions)
Figure 65. India Recombinant Parvovirus Antigens Market Size 2027-2032 ($ millions)
Figure 66. Australia Recombinant Parvovirus Antigens Market Size 2027-2032 ($ millions)
Figure 67. Germany Recombinant Parvovirus Antigens Market Size 2027-2032 ($ millions)
Figure 68. France Recombinant Parvovirus Antigens Market Size 2027-2032 ($ millions)
Figure 69. UK Recombinant Parvovirus Antigens Market Size 2027-2032 ($ millions)
Figure 70. Italy Recombinant Parvovirus Antigens Market Size 2027-2032 ($ millions)
Figure 71. Russia Recombinant Parvovirus Antigens Market Size 2027-2032 ($ millions)
Figure 72. Egypt Recombinant Parvovirus Antigens Market Size 2027-2032 ($ millions)
Figure 73. South Africa Recombinant Parvovirus Antigens Market Size 2027-2032 ($ millions)
Figure 74. Israel Recombinant Parvovirus Antigens Market Size 2027-2032 ($ millions)
Figure 75. Turkey Recombinant Parvovirus Antigens Market Size 2027-2032 ($ millions)
Figure 76. Global Recombinant Parvovirus Antigens Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Recombinant Parvovirus Antigens Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Recombinant Parvovirus Antigens Market Size 2027-2032 ($ millions)